CMP for Pain, Postoperative

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pain, Postoperative+1 More
CMP - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to do a nerve block that may minimize the amount of pain medication needed post-operatively.

Eligible Conditions
  • Pain, Postoperative
  • Arthroplasty

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 24 hours

24 hours
Measurement of opioid use
Measurement of the pain control

Trial Safety

Trial Design

2 Treatment Groups

Fascia iliaca
1 of 2
CMP
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: CMP · No Placebo Group · N/A

CMP
Drug
Experimental Group · 1 Intervention: CMP · Intervention Types: Drug
Fascia iliaca
Drug
ActiveComparator Group · 1 Intervention: Fascia Illica · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CMP
2008
N/A
~20

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 hours

Who is running the clinical trial?

Loyola UniversityLead Sponsor
146 Previous Clinical Trials
30,051 Total Patients Enrolled
3 Trials studying Pain, Postoperative
181 Patients Enrolled for Pain, Postoperative

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: November 30th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References